#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antisynthetase syndrome Transferrin decreased Extranodal marginal zone B-cell lymphoma (MALT type) Neuropathic arthropathy Immunoglobulin G4 related disease Cystic fibrosis gastrointestinal disease Anal squamous cell carcinoma Candida infection Netherton's syndrome Acute on chronic liver failure Deafness Bone marrow disorder Mixed-type liposarcoma Acquired C1 inhibitor deficiency Malignant fibrous histiocytoma More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia Hereditary ataxia – Basic Information Prader-Willi syndrome – Diagnostics Primary mediastinal large B-cell lymphoma – Diagnostics Behcet’s syndrome Langerhans’ cell histiocytosis – Diagnostics Shprintzen-Goldberg syndrome – Treatment Splenic marginal zone lymphoma – Diagnostics Alveolar rhabdomyosarcoma – Basic Information Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludrocortisone Ivabradine Hydrochloride Anifrolumab Tadekinig Alfa Pyruvic Acid Adapalene Csm-Gw Sapablursen Irinotecan Hydrochloride GSKVX000000039711 Dimeticone Amoxicillin Sodium Isavuconazonium Sulfate HTL0022537 Plasma Imipenem Anhydrate Mva-209-Fsp-B4 Antipsychotics Resatorvid Ptg-Carcik-Cd19 More therapies…

    Learn about Your Condition

    Altered state of consciousness Elderly Transitional cell carcinoma Nephrogenic anaemia COVID-19 Urticaria Tachypnoea Erythema migrans Retinopathy of prematurity Metabolic syndrome Androgenetic alopecia Anxiety disorder Infantile spasms Alveolar proteinosis Obstructive pancreatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Respiratory syncytial virus infection

  • Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Belgium The Netherlands

  • Study of nirsevimab and RSV vaccine (Abrysvo) for prevention of respiratory syncytial virus infection in infants during their first year of life

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiolitis
    • Respiratory syncytial virus infection
    France

  • Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Germany Italy Spain

  • A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Bulgaria Poland

  • Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Sweden

  • Study on the Safety and Immune Response of rBCG-N-RSV Vaccine Compared to BCG Vaccine in Adults Over 60 with Respiratory Syncytial Virus (RSV) Concerns

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Greece
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!